Global Enteric Empty Capsules Market growing at a CAGR of 8.3% from 2023 to 2031
Category : Pharmaceuticals And Healthcare | Published Date : Oct 2023
Key Market Overview
Consegic Business Intelligence analyzes that the enteric empty capsules market is predicted to grow at a compound annual growth rate of 8.3% from 2023 to 2031 and is expected to reach USD 148.23 million in 2031 and 78.47 million in 2023 which was valued at USD 73.31 million in 2022.
The report highlights the increasing prevalence of chronic diseases, which is augmenting the global market growth. Consegic Business Intelligence study also provides insights into the market's competitive landscape, market segmentation, regional outlook, and emerging technologies in the enteric empty capsules market.
Global Enteric Empty Capsules Market By Overview
The enteric empty capsules market is bifurcated into type, therapeutic application, and end user. Based on type, the market is segmented into gelatin and non-gelatin. In 2022, the gelatin segment dominated the overall enteric empty capsules market. Based on therapeutic application, the market is segmented into antibiotic and antibacterial drugs, antacid and antiflatulent preparations, dietary supplements, cardiovascular therapy drugs, and others. In 2022, the dietary supplements segment dominated the overall enteric empty capsules market. Based on end user, the market is segmented into pharmaceutical and biopharmaceutical companies, cosmetic companies, nutraceutical companies, clinical research organizations, and others. In 2022, the nutraceutical companies segment dominated the overall enteric empty capsules market.
Get Free SampleMarket Dynamics
Driver:
- Increasing prevalence of chronic diseases is accelerating the market growth.
- Rising demand for nutraceuticals is boosting market growth.
Restraints:
- Dietary restrictions is hampering the market growth.
Market Segmentation:
| Report Attributes | Report Details |
| By Type | Gelatin and Non-Gelatin |
| By Therapeutic Application | Antibiotic and Antibacterial Drugs, Antacid and Antiflatulent Preparations, Dietary Supplements, Cardiovascular Therapy Drugs, and Others |
| By End User | Pharmaceutical and Biopharmaceutical Companies, Cosmetic Companies, Nutraceutical Companies, Clinical Research Organizations, and Others |
| By Region | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Competitive Landscape :
The market is dominated by certain major companies such as Lonza Group Ltd, Evonik, and The Roxlor Group, which have a strong market position in the current market circumstances. These companies are continuously leveraging new technologies to develop innovative solutions. Furthermore, the enteric empty capsules market is expected to witness substantial growth in the coming years due to advancements in capsule manufacturing technology in key regions such as North America, Asia Pacific, and others.
The market is characterized by intense competition, with companies focusing on expanding their product offerings and increasing their market share through mergers, acquisitions, and partnerships.
- Lonza Group Ltd
- Evonik
- The Roxlor Group
- CapsCanada Corporation
- Qualicaps Inc.
- CapsulCN International Co., Ltd.
- Natural Capsules Limited
- Snail Pharma Industry Co. Ltd
- ACG Group
- Anhui Huangshan Capsule Co., Ltd.